Stay updated on ADXS-503 & Pembro in Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the ADXS-503 & Pembro in Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ADXS-503 & Pembro in Lung Cancer Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T15:13:21.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1 on the error page.
    Difference
    0.2%
    Check dated 2026-10-11T15:09:57.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error with a minimal header and a Home link, indicating the page is currently inaccessible.
    Difference
    0.5%
    Check dated 2026-09-27T16:51:20.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    Accessing the study record now results in a 403 Forbidden error page, indicating restricted access. The rest of the site chrome remains, but the study content is not viewable.
    Difference
    20%
    Check dated 2026-09-20T05:19:43.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The page's revision label changed from v3.6.5 to v3.6.6, signaling a minor update to the study record’s documentation or formatting. This appears to be a backend/editorial update rather than changes to study data or eligibility information.
    Difference
    0.0%
    Check dated 2026-08-29T23:39:11.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    Added the Study Protocol and Statistical Analysis Plan (PDF) to the Study Documents section, along with related metadata and MeSH terms. This expands the published documentation of the trial's design and planned analyses.
    Difference
    66%
    Check dated 2026-08-15T23:14:49.000Z thumbnail image

Stay in the know with updates to ADXS-503 & Pembro in Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ADXS-503 & Pembro in Lung Cancer Clinical Trial page.